Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -29.724% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. Cc1nnsc1C(=O)N1CCCC(C(=O)c2ccc(C(F)(F)F)cc2)C1
b. CCc1ccc(Nc2n[n+](C)c(-c3ccncc3)s2)cc1.[Cl-]
Answer: b. CCc1ccc(Nc2n[n+](C)c(-c3ccncc3)s2)cc1.[Cl-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1ccc(Nc2n[n+](C)c(-c3ccncc3)s2)cc1.[Cl-]
CCc1ccc(Nc2n[n+](C)c(-c3ccncc3)s2)cc1.[Cl-]
N-(4-ethylphenyl)-4-methyl-5-pyridin-4-yl-1,3,4-thiadiazol-4-ium-2-amine;chloride